Avance Biosciences, Inc., a leading biological testing company supporting drug development and manufacturing, announced today that its Houston facility was inspected by the U.S. Food and Drug Administration on October 01 through October 04, 2018. This inspection focused on the firm’s quality management system, operation procedures, and data integrity, as well as various analyses performed on a specific drug product from one of its clients. This inspection resulted in no FDA Form 483 (inspectional observation).
As a provider of biological testing ...
Read More →
